A detailed history of Man Group PLC transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Man Group PLC holds 10,637 shares of CODX stock, worth $13,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,637
Previous 74,095 85.64%
Holding current value
$13,296
Previous $98,000 88.78%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.06 - $1.42 $67,265 - $90,110
-63,458 Reduced 85.64%
10,637 $11,000
Q2 2023

Aug 14, 2023

BUY
$1.04 - $1.64 $23,041 - $36,334
22,155 Added 42.65%
74,095 $82,000
Q4 2022

Feb 14, 2023

BUY
$2.32 - $3.68 $2,088 - $3,312
900 Added 1.76%
51,940 $130,000
Q3 2022

Nov 14, 2022

SELL
$2.87 - $7.01 $39,387 - $96,205
-13,724 Reduced 21.19%
51,040 $164,000
Q2 2022

Aug 15, 2022

BUY
$3.76 - $6.29 $72,778 - $121,749
19,356 Added 42.63%
64,764 $363,000
Q1 2022

May 16, 2022

BUY
$5.03 - $9.61 $228,402 - $436,370
45,408 New
45,408 $281,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $42.2M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.